I was wondering if anybody who has knowledge in the field of intellectual property rights might be able to shine some light on this.
The company (Algernon pharmaceuticals) a Canadian company, is repurposing the drug "ifenprodil" for multiple uses including IPF, Chronic Cough, and Covid-19...